During checkout, this product may be reported as "Out of Stock" with an Estimated Availability date. The Actual Availability date for this product may be earlier. Send inquiries regarding Actual Availability date, including the catalog number, to discoverysciences@lifetech.com.

Tango™ CNR1-bla U2OS Cells

Catalog number:  K1513

Related applications:

Pharma & Biopharma

Back to top


The Tango™ CNR1-bla U2OS cells contain the human Cannabinoid Receptor 1 (CNR1) linked to a TEV protease site and a Gal4-VP16 transcription factor stably integrated into the Tango™ GPCR-bla U2OS parental cell line. This parental cell line stably expresses a beta-arrestin/TEV protease fusion protein and the beta-lactamase (bla) reporter gene under the control of a UAS response element.

The Tango™ CNR1 cell line has been functionally validated for Z'-factor and EC50 concentrations of CP 55,940. The CNR1 cells have been tested for assay performance under variable assay conditions. These data are available in the Validation & Assay Performance Summary in the Manuals and Brochures section.
For Research Use Only. Not for use in diagnostic procedures.


Accession Number: NM_016083
Assay Entry: Cell-based beta-arrestin recruitment
Cell Line: U2OS
Cell State: Dividing Cells
Cytoplasmic Tail: Tail from AVPR2 GPCR
Druggable Target: GPCRs
Gene Symbol: CNR1
Population Status: Single Cell Clone Origin
Product Line: Tango™
Reporter Gene: BLA (Beta-Lactamase)
System Type: Tango™
Target Entry: CNR1
Detection Method: Fluorescent

Contents & storage

(LiveBLAzer™-FRET B/G Loading Kit, Solution D and other materials are required separately; please refer to the protocol).
o Tango™ CNR1-bla U2OS cells
o Tango™ CNR1-bla U2OS Assay Protocol
o Certificate of Analysis
The Tango™ CNR1-bla U2OS cells are shipped on dry ice and should be stored in liquid nitrogen immediately upon receipt.